1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow JNJ-42165279 2.5 - 500 mg oral: new trials by email Literature Review of JNJ-42165279 2.5 - 500 mg oral trials Research Report on JNJ-42165279 2.5 - 500 mg oral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants JNJ-42165279 2.5 - 500 mg oral, Placebo, JNJ-42165279 100 mg oral - Healthy Volunteers, Pharmacokinetics | Phase 1 | Completed | Janssen-Cilag International NV | 29 | 2011-08-01 | 2017-07-06 |
Janssen-Cilag International NV (1)
Belgium (1)